Among the largest pharmaceutical companies, both GlaxoSmithKline Plc and Novartis AG are global leaders in consumer health. While manufacturing disruptions and unfavourable market conditions in key geographies have hindered recent performance, these companies have taken steps to promote future success. In April 2014, GSK and Novartis announced plans to create a consumer health joint venture to be completed in the first half of 2015 that has the potential to become the new global industry leader.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Euromonitor International's report on GlaxoSmithKline Plc delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.
Company and market share data provide a detailed look at the financial position of GlaxoSmithKline Plc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of GlaxoSmithKline Plc.
Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.
Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.